Works in OncoImmunology, 2013, Vol 2, Issue 1

Results: 39

Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22837-1, doi. 10.4161/onci.22837

By:

Adler, Adam J.;
Vella, Anthony T.

Publication type:

Article

Victories and deceptions in tumor immunology Stimuvax®.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e23687-1, doi. 10.4161/onci.23687

By:

Kroemer, Guido;
Zitvogel, Laurence;
Galluzzi, Lorenzo

Publication type:

Article

Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors.

Published in:

2013

By:

Correia, Daniel V.;
Lopes, António;
Silva-Santos, Bruno

Publication type:

Opinion

Trial watch Monoclonal antibodies in cancer therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22789-1, doi. 10.4161/onci.22789

By:

Vacchelli, Erika;
Eggermont, Alexander;
Galon, Jérôme;
Sautès-Fridman, Catherine;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Vemurafenib enhances MHC induction in BRAFV600E homozygous melanoma cells.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22890-1, doi. 10.4161/onci.22890

By:

Sapkota, Bishu;
Hill, Charles E.;
Pollack, Brian P.

Publication type:

Article

Involvement of STAT3 in immune evasion during lung tumorigenesis.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22653-1, doi. 10.4161/onci.22653

By:

Kida, Hiroshi;
Ihara, Shoichi;
Kumanogoh, Atsushi

Publication type:

Article

Predicting the efficacy of cancer vaccines by evaluating T-cell responses.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22616-1, doi. 10.4161/onci.22616

By:

van Duikeren, Suzanne;
Arens, Ramon

Publication type:

Article

Signaling via MYD88 in the pancreatic tumor microenvironment A double-edged sword.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22567-1, doi. 10.4161/onci.22567

By:

Zambirinis, Constantinos P.;
Miller, George

Publication type:

Article

Cell type specific gene delivery by lentiviral vectors New options in immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22566-1, doi. 10.4161/onci.22566

By:

Qi Zhou;
Buchholz, Christian J.

Publication type:

Article

NKT cell adjuvants in therapeutic vaccines against hematological cancers.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22615-1, doi. 10.4161/onci.22615

By:

Mattarollo, Stephen R.;
Smyth, Mark J.

Publication type:

Article

Unraveling the physiological functions of exosome secretion by tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22565-1, doi. 10.4161/onci.22565

By:

Bobrie, Angélique;
Théry, Clotilde

Publication type:

Article

The role of soluble CD40L in immunosuppression.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22546-1, doi. 10.4161/onci.22546

By:

Schlom, Jeffrey;
Jochems, Caroline;
Gulley, James L.;
Huang, Jianping

Publication type:

Article

Lymphoid neogenesis in melanoma What does it tell us?

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22505-1, doi. 10.4161/onci.22505

By:

van Baren, Nicolas;
Baurain, Jean-François;
Coulie, Pierre G.

Publication type:

Article

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22450-1, doi. 10.4161/onci.22450

By:

Pedroza-Gonzalez, Alexander;
Kwekkeboom, Jaap;
Sprengers, Dave

Publication type:

Article

In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22449-1, doi. 10.4161/onci.22449

By:

Galili, Uri

Publication type:

Article

The adenosinergic system in cancer Key therapeutic target.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22448-1, doi. 10.4161/onci.22448

By:

Sorrentino, Rosalinda;
Pinto, Aldo;
Morello, Silvana

Publication type:

Article

T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22841-1, doi. 10.4161/onci.22841

By:

Tabbekh, Mouna;
Mokrani-Hammani, M'Barka;
Bismuth, Georges;
Mami-Chouaib, Fathia

Publication type:

Article

Establishing the role of tyrosine kinase 2 in cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22840-1, doi. 10.4161/onci.22840

By:

Übel, Caroline;
Mousset, Stephanie;
Trufa, Denis;
Sirbu, Horia;
Finotto, Susetta

Publication type:

Article

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22410-1, doi. 10.4161/onci.22410

By:

Schendel, Dolores J.;
Frankenberger, Bernhard

Publication type:

Article

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22409-1, doi. 10.4161/onci.22409

By:

Senovilla, Laura;
Vitale, Ilio;
Martins, Isabelle;
Kepp, Oliver;
Galluzzi, Lorenzo;
Zitvogel, Laurence;
Castedo, Maria;
Kroemer, Guido

Publication type:

Article

The role of Type I interferons in immunoregulation of breast cancer metastasisto the bone.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22339-1, doi. 10.4161/onci.22339

By:

Slaney, Clare Y.;
Möller, Andreas;
Hertzog, Paul J.;
Parker, Belinda S.

Publication type:

Article

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cells.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22944-1, doi. 10.4161/onci.22944

By:

Decrausaz, Loane;
Pythoud, Christelle;
Domingos-Pereira, Sonia;
Derré, Laurent;
Jichlinski, Patrice;
Nardelli-Haefliger, Denise

Publication type:

Article

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22355-1, doi. 10.4161/onci.22355

By:

Sceneay, Jaclyn;
Parker, Belinda S.;
Smyth, Mark J.;
Möller, Andreas

Publication type:

Article

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+ regulatory T cells and are associated with poor prognosis in breast cancer patients.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22338-1, doi. 10.4161/onci.22338

By:

Sisirak, Vanja;
Faget, Julien;
Vey, Nelly;
Blay, Jean-Yves;
Ménétrier-Caux, Christine;
Caux, Christophe;
Bendriss-Vermare, Nathalie

Publication type:

Article

NK cell-released exosomes Natural nanobullets against tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22337-1, doi. 10.4161/onci.22337

By:

Fais, Stefano

Publication type:

Article

Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22590-1, doi. 10.4161/onci.22590

By:

Shao-An Xue;
Liquan Gao;
Ahmadi, Maryam;
Ghorashian, Sara;
Barros, Rafael D.;
Pospori, Constandina;
Holler, Angelika;
Wright, Graham;
Thomas, Sharyn;
Topp, Max;
Morris, Emma C.;
Stauss, Hans J.

Publication type:

Article

Targeting PI3Kδ One man's meat is another man's poison.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22272-1, doi. 10.4161/onci.22272

By:

Prchal-Murphy, Michaela;
Putz, Eva Maria;
Freissmuth, Michael;
Sexl, Veronika;
Zebedin-Brandl, Eva

Publication type:

Article

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. 22664-1, doi. 10.4161/onci.22664

By:

Kandalaft, Lana E.;
Powell Jr., Daniel J.;
Chiang, Cheryl L.;
Tanyi, Janos;
Kim, Sarah;
Bosch, Marnix;
Montone, Kathy;
Mick, Rosemarie;
Levine, Bruce L.;
Torigian, Drew A.;
June, Carl H.;
Coukos, George

Publication type:

Article

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22647-1, doi. 10.4161/onci.22647

By:

Xinrong Ma;
Dawn Holt;
Kundu, Namita;
Reader, Jocelyn;
Goloubeva, Olga;
Take, Yukinori;
Fulton, Amy M.

Publication type:

Article

Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22246-1, doi. 10.4161/onci.22246

By:

Walter, Steffen;
Weinschenk, Toni;
Reinhardt, Carsten;
Singh-Jasuj, Harpreet

Publication type:

Article

Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e23033-1, doi. 10.4161/onci.23033

By:

Vonderheide, Robert H.;
Burg, Jennifer M.;
Mick, Rosemarie;
Trosko, Jennifer A.;
Dongguang Li;
Naveed Shaik, M.;
Tolcher, Anthony W.;
Hamid, Omid

Publication type:

Article

Metastamir-mediated immune evasion miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22245-1, doi. 10.4161/onci.22245

By:

Tsukerman, Pinchas;
Enk, Jonatan;
Mandelboim, Ofer

Publication type:

Article

NKG2D ligands link oncogenic RAS to innate immunity.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22244-1, doi. 10.4161/onci.22244

By:

Ho, Samantha S. W.;
Gasser, Stephan

Publication type:

Article

Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22197-1, doi. 10.4161/onci.22197

By:

Kono, Koji;
Mimura, Kousaku

Publication type:

Article

A delicate balance CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22107-1, doi. 10.4161/onci.22107

By:

hompson, Linda F.;
Tsukamoto, Hiroki;
Chernogorova, Petya;
Zeiser, Robert

Publication type:

Article

Improving the outcome of adoptive cell transfer by targeting tumor escape.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22059-1, doi. 10.4161/onci.22059

By:

Kaluza, Karen M.;
Vile, Richard

Publication type:

Article

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22058-1, doi. 10.4161/onci.22058

By:

Bellone, Matteo;
Calcinotto, Arianna;
Filipazzi, Paola;
De Milito, Angelo;
Fais, Stefano;
Rivoltini, Licia

Publication type:

Article

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22620-1, doi. 10.4161/onci.22620

By:

Armeanu-Ebinger, Sorin;
Hoh, Alexander;
Wenz, Julia;
Fuchs, Joerg

Publication type:

Article

An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22978-1, doi. 10.4161/onci.22978

By:

Kwong, Christina;
Gilman-Sachs, Alice;
Beaman, Kenneth

Publication type:

Article

Works in OncoImmunology, 2013, Vol 2, Issue 1

Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation.

Victories and deceptions in tumor immunology Stimuvax®.

Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors.

Trial watch Monoclonal antibodies in cancer therapy.

Vemurafenib enhances MHC induction in BRAF<sub>V600E</sub> homozygous melanoma cells.

Involvement of STAT3 in immune evasion during lung tumorigenesis.

Predicting the efficacy of cancer vaccines by evaluating T-cell responses.

Signaling via MYD88 in the pancreatic tumor microenvironment A double-edged sword.

Cell type specific gene delivery by lentiviral vectors New options in immunotherapy.

NKT cell adjuvants in therapeutic vaccines against hematological cancers.

Unraveling the physiological functions of exosome secretion by tumors.

The role of soluble CD40L in immunosuppression.

Lymphoid neogenesis in melanoma What does it tell us?

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment.

In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids.

The adenosinergic system in cancer Key therapeutic target.

T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Establishing the role of tyrosine kinase 2 in cancer.

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity.

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells.

The role of Type I interferons in immunoregulation of breast cancer metastasisto the bone.

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8<sup>+</sup> T cells.

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche.

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3<sup>+</sup> regulatory T cells and are associated with poor prognosis in breast cancer patients.

NK cell-released exosomes Natural nanobullets against tumors.

Human MHC Class I-restricted high avidity CD4<sup>+</sup> T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

Targeting PI3Kδ One man's meat is another man's poison.

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer.

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE<sub>2</sub>-mediated immunosuppression and inhibits breast cancer metastasis.

Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901.

Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors.

Metastamir-mediated immune evasion miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor.

NKG2D ligands link oncogenic RAS to innate immunity.

Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.

A delicate balance CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect.

Improving the outcome of adoptive cell transfer by targeting tumor escape.

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma.

An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.